U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07744828) titled 'A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male Participants' on July 30.
Brief Summary: The purpose of this study is to assess the PK comparability and compare safety and tolerability of DRL\_AB administered via an auto injector (AI) or prefilled syringe (PFS) in healthy male participants.
Study Start Date: Aug. 19
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
BIOLOGICAL: DRL_AB
DRL\_AB administered as a SC injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Dr. Reddy's Laboratories Limited
Published by HT Digital Content Services with permission from Health Daily Digest....